Cardinal Health Hits New 12-Month High After Analyst Upgrade

Shares of the healthcare services company rise after Leerink Partners boosts price target.

Published on Mar. 2, 2026

Got story updates? Submit your updates here. ›

Shares of Cardinal Health, Inc. (NYSE:CAH) reached a new 52-week high after investment firm Leerink Partners raised its price target on the stock from $268.00 to $275.00 and maintained an "outperform" rating. The stock traded as high as $232.97 on the day.

Why it matters

Cardinal Health is a major player in the healthcare services and distribution industry, so an analyst upgrade and new 52-week high for the stock could signal growing confidence in the company's performance and outlook.

The details

Leerink Partners cited the price target increase in a research report, noting the company's strong fundamentals. Several other analysts have also issued positive reports on Cardinal Health recently, with the stock receiving a "Moderate Buy" consensus rating from Wall Street.

  • Cardinal Health stock reached a new 52-week high on Monday, March 2, 2026.

The players

Cardinal Health, Inc.

A multinational healthcare services and products company headquartered in Dublin, Ohio that provides supply chain and distribution services for the healthcare sector.

Leerink Partners

An investment firm that covers Cardinal Health and raised its price target on the stock.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

The takeaway

The new 52-week high for Cardinal Health stock suggests Wall Street sees continued growth potential for the healthcare services company, which could bode well for its future performance.